Drugs with this side effect
- 4-AP: 2%
- 4-methylpyrazole
- 5-ASA: rare, 0.8% - 9%
- 5-aza-2'-deoxycytidine: 1.23% - 12%
- 5-azacytidine: common, 0% - 6.82%
- ALX 111
- AMD3100: common
- Anidulafungin: 6.67% - 6.98%
- BPTI
- Benicar-HCT
- Bivalirudin: 4.63% - 5.16%
- CAS 76095-16-4
- CAS 76420-72-9: postmarketing
- CGP 19835A: common
- Cancidas
- DFMO: 1.9% - 2.5%
- Eptifibatide: 0.0962%
- Estrofem
- FK463
- Fe(III
- Forteo: 5.2%
- Goserelin: 1-10%
- Implanon
- K779: 2% - 9%
- Kaluril
- L-Dmp
- LY146032: postmarketing, uncommon, 1% - 6.9%
- Leuprorelin
- LiOH
- Lisinopril: postmarketing, uncommon, 0.5% - 1.9%
- Lovaza: 3% - 3.1%
- Lu AA21004
- Lyxumia
- MK-462
- Meropenem anhydrous
- Metrodin: 1.7% - 3.5%
- N-acetylcysteine
- NovoLog: 6% - 9%
- Octreotide: common
- Oestrogen: 5% - 11%
- Optison: rare
- PCI-32765
- PGE1: 1% - 11%
- Photofrin: 0% - 6.06%
- Photofrin II: common
- Refludan
- SU5416: 7%
- Saxagliptin
- Stalevo 50
- Triptorelin: 1.7%
- Trisequens
- UDCA: postmarketing, 10% - 16.8%
- VACV: 0% - 4%
- abiraterone: 0% - 0.2%
- acamprosate: frequent
- acarbose
- acebutolol: 1% - 6%
- acetaminophen: 1.3%
- acitretin: postmarketing
- adefovir: 3%
- adefovir dipivoxil: postmarketing, common, 3%
- afatinib: common
- agomelatine
- alendronate: 0% - 4.2%
- alfuzosin: 1.27%
- aliskiren
- allopurinol
- almotriptan: infrequent
- alprazolam: frequent
- alvimopan
- amantadine: common
- amiloride
- amiodarone
- amisulpride: 0% - 1%
- amlodipine
- amlodipine besylate
- amphetamine
- amphotericin B
- anagrelide: 5.2% - 6%
- anastrozole: 5.46% - 6.66%
- apremilast
- aprepitant: 0.4% - 8.4%
- aripiprazole: common, 1% - 15%
- arsenic
- arsenic trioxide
- articaine
- asenapine: 4%
- aspirin
- atazanavir
- atenolol
- atomoxetine: 4% - 8%
- atorvastatin: 1.3% - 4.7%
- atovaquone: 5% - 10%
- auranofin
- avanafil
- axitinib: 0% - 10%
- azithromycin: postmarketing, 1% - 9%
- baclofen
- balsalazide: 1.93% - 2%
- benazepril
- bendamustine: 0%
- bepridil: 6.81%
- betahistine: common
- betaxolol: 3.9% - 7.4%
- bexarotene: 10%
- bezafibrate: 3.4% - 11%
- bicalutamide: 1-5% - 7%
- bimatoprost
- bisoprolol
- boceprevir: common
- bortezomib: 0% - 13.2%
- bosentan
- brimonidine
- brinzolamide: postmarketing
- bromocriptine: 4%
- budesonide: 3.41% - 11.7%
- bupivacaine: 1.96% - 2.43%
- buprenorphine: 2.15% - 5.56%
- bupropion: postmarketing, frequent, 3.1% - 4.7%
- busulfan: 44%
- cabazitaxel: 0%
- cabergoline: 2.38% - 6.93%
- cabozantinib: 0% - 11%
- candesartan
- candesartan cilexetil
- capecitabine: 1% - 8%
- captopril
- carbamazepine: 10%
- carbidopa: 0.6% - 1.1%
- carnitine: 5% - 9%
- carvedilol
- cefaclor
- cefadroxil
- cefdinir
- cefditoren
- cefixime: 3%
- cefpodoxime
- ceftobiprole
- ceftriaxone
- cefuroxime
- cefuroxime axetil
- celecoxib: 8.8% - 12.8%
- cephalexin
- cephem
- cerivastatin: 3.8%
- cetirizine: 0.844%
- cevimeline: 7.8%
- chlorhexidine
- ciclesonide: 0.1% - 0.2%
- cidofovir
- cilazapril: postmarketing
- cilostazol: 6%
- cinacalcet: uncommon, 8%
- ciprofloxacin: postmarketing, uncommon, 1%
- citalopram: infrequent, frequent, 1% - 6%
- clarithromycin: postmarketing, uncommon, 2% - 3%
- clindamycin
- clindamycin phosphate
- clomipramine: 13% - 22%
- clonazepam
- clopidogrel: common, 0.1% - 2%
- clozapine: 8% - 14%
- cobicistat: common
- colesevelam: 2.76% - 8.3%
- colestimide: common
- colestipol
- colestyramine: common
- conjugated estrogens
- copolymer 1
- cortisol
- crizotinib: 0% - 8%
- cyanocobalamin
- cyclobenzaprine: 0% - 4%
- cyproterone
- cyproterone acetate
- cysteamine: common
- dabigatran
- dabigatran etexilate
- dalteparin
- danazol
- dantrolene
- darifenacin: 2.67% - 8.38%
- darunavir: 0% - 1.83%
- dasatinib
- deferasirox: common
- deferiprone
- delamanid
- delavirdine
- demethyl
- deprenyl: 4% - 5%
- desloratadine
- desmopressin
- dexamethasone
- dexamethasone sodium phosphate
- dextrorphan
- diazepam
- diclofenac: postmarketing, common, 0% - 9.62%
- dicyclomine: postmarketing
- didanosine: postmarketing
- diflunisal
- dihydroergotamine: infrequent
- diltiazem: 0% - 6.12%
- dipyridamole: 1%
- disopyramide
- docetaxel: 1% - 5%
- dolasetron: 2.2% - 12.8%
- donepezil: frequent
- dorzolamide
- dothiepin
- doxazosin: 1% - 2.4%
- doxepin: rare
- doxercalciferol: 4.9%
- doxorubicin: common, 0% - 14%
- doxycycline: 3.6% - 6.1%
- doxycycline hyclate: 6.1%
- dronedarone
- duloxetine: common, frequent, 2% - 5%
- efavirenz: 0% - 6%
- eletriptan: 1% - 2%
- eliglustat: 1.89% - 6.6%
- elvitegravir: uncommon
- emtricitabine: postmarketing, common
- entacapone: 2%
- entecavir: uncommon, common, 0% - 2%
- eplerenone
- eprosartan
- eribulin
- erlotinib: 12%
- ertapenem
- eslicarbazepine acetate
- esmolol
- esomeprazole magnesium
- estazolam: 2%
- estradiol: 0% - 9.23%
- estradiol valerate
- etidronate
- etodolac: 10%
- etoricoxib
- everolimus: common
- exemestane: common, 2-5%
- exenatide: 0.897% - 7.4%
- ezetimibe
- famciclovir: 1.3% - 5.2%
- famotidine
- febuxostat: uncommon
- felbamate: 2% - 12.3%
- felodipine
- fenofibrate: 0.533% - 4.7%
- fenofibric acid: 2.45% - 4.7%
- fenoprofen
- fentanyl: very rare, postmarketing
- ferumoxytol: postmarketing
- fesoterodine: 1.6% - 2.3%
- fexofenadine: 1.3% - 4.7%
- fidaxomicin
- flecainide
- flucloxacillin
- fluconazole: postmarketing, 0.2% - 1.3%
- flunisolide: 2.1% - 3.5%
- fluoxetine: common, 6% - 11%
- flurbiprofen
- fluvastatin: common, 0.3% - 7.9%
- fluvoxamine: common, frequent, 1% - 13.8%
- fondaparinux: rare, 2.4% - 2.58%
- formoterol
- fosaprepitant
- fosaprepitant dimeglumine: 0.4% - 0.8%
- foscarnet
- fosfomycin: 1.1% - 2.1%
- fosfomycin trometamol
- fosinopril
- fosphenytoin: infrequent
- frovatriptan
- fusidic acid: 3% - 3.7%
- gabapentin: 0.5% - 16%
- gadobenate dimeglumine
- gadodiamide
- gadofosveset
- gadolinium: 1.22%
- gadoversetamide: 0.421% - 1.22%
- galantamine: 1.8% - 5%
- ganciclovir
- gatifloxacin
- gemfibrozil: postmarketing, 19.6%
- gemifloxacin
- glibenclamide
- gliclazide
- glimepiride
- glipizide
- glycerol phenylbutyrate: 4.55% - 6.67%
- glycopyrrolate: uncommon
- granisetron: 3% - 6%
- guanfacine: postmarketing
- halofantrine
- haloperidol
- histamine
- hydrochlorothiazide
- hydromorphone: 3.56%
- hydroxocobalamin
- hydroxybutyrate
- ibandronate: 3.6% - 12%
- ibuprofen: 1.32% - 12%
- icodextrin: 4% - 5%
- imatinib: very common, 0% - 27%
- imiquimod: 1% - 2%
- indapamide: 4%
- indinavir: postmarketing, 0.9% - 1.5%
- indomethacin: 1% - 3%
- insulin detemir: 1.2% - 1.8%
- iodixanol
- iopromide
- iotrolan
- ioxilan
- ipratropium bromide: common, 0% - 5%
- irbesartan: uncommon, 0.3% - 2.1%
- irbesartan-hydrochlorothiazide: 0.3% - 2.1%
- irinotecan: 0% - 10.5%
- isomannide
- isosorbide-5-mononitrate
- itraconazole: postmarketing
- ketoconazole
- ketoprofen: 11% - 11.5%
- ketorolac: 12%
- ketorolac tromethamine: postmarketing, 12%
- labetalol: 0% - 3%
- lacosamide
- lamivudine: 2% - 5%
- lamotrigine: 2% - 7%
- lanreotide
- lansoprazole
- lanthanum: postmarketing
- lapatinib: very common, 0% - 3%
- leflunomide: 5% - 13%
- lenalidomide: postmarketing, uncommon, common
- lercanidipine
- letrozole: common, 3% - 6%
- leucovorin
- leuprorelin acetate
- levetiracetam: 2.8%
- levodopa/carbidopa: 0.6%
- levonorgestrel
- linaclotide
- linezolid
- liraglutide: postmarketing
- lithium
- lithium carbonate
- lomefloxacin
- lomitapide
- loperamide: postmarketing
- loratadine
- losartan: 1.1% - 4%
- lovastatin: 1% - 1.6%
- lubiprostone: 2%
- lurasidone: 5% - 11%
- mebeverine
- mefenamic acid
- mefloquine: postmarketing
- megestrol: 0% - 4%
- melatonin
- meloxicam: 2.7% - 9.5%
- memantine
- meropenem
- mesna: 3.4% - 6%
- metformin: 4.2% - 12.5%
- methocarbamol
- methotrexate
- methylphenidate: common, 2% - 9%
- methylprednisolone
- methylprednisolone sodium succinate
- metronidazole
- mexiletine
- midodrine
- miglustat: 0% - 7%
- milnacipran
- minocycline: 0% - 4%
- mirabegron
- mirtazapine
- misoprostol: 2%
- mitotane
- mitoxantrone: 5-14%
- moclobemide
- modafinil: 2%
- moexiprilat
- mometasone: 3% - 5%
- mometasone furoate: 3% - 5%
- monomethylfumarate: 5%
- montelukast: postmarketing, 2.1%
- morphine
- moxifloxacin: 1%
- mycophenolate mofetil: 0.6% - 22.4%
- mycophenolic acid: 13.8% - 23%
- n-3 PUFA: 3%
- nabilone
- nabumetone: 13%
- nadolol
- nalbuphine
- naproxen: postmarketing, 14%
- nateglinide: common
- nedocromil sodium
- nefazodone
- nelfinavir
- niacin
- nicardipine
- nicorandil: common
- nicotine: 1.2%
- nifedipine: 1.2% - 1.5%
- nilotinib: common, 0% - 6%
- nilutamide
- nisoldipine
- nitazoxanide
- nitrofurantoin
- nizatidine: 3.6%
- norfloxacin
- ofloxacin
- olanzapine: 3% - 11%
- olmesartan: common, 0.189% - 1.26%
- olmesartan medoxomil
- olsalazine: 4%
- omeprazole: very rare, 3%
- orlistat: common
- oseltamivir: postmarketing
- oxaliplatin: common, 0% - 10%
- oxaprozin
- oxcarbazepine: 0% - 6%
- oxprenolol
- oxybutynin: uncommon, 4.5% - 6%
- oxycodone
- oxymorphone
- paclitaxel: common
- paliperidone: 5% - 6%
- palonosetron
- pamidronate: uncommon, 0% - 22.6%
- pantoprazole
- parecoxib
- paricalcitol
- paroxetine: common, 2% - 13%
- pazopanib
- pegaptanib
- pegaptanib sodium
- pemetrexed: 0% - 1%
- penbutolol: 2.7% - 5.3%
- pentamidine
- pentosan polysulfate: 1% - 2%
- pentostatin
- pentoxifylline: 2.8% - 9.6%
- pergolide: frequent, 6.4%
- perindopril: 0.3% - 1.9%
- perindopril erbumine
- phenytoin: infrequent
- pilocarpine: 7%
- piperacillin: uncommon
- pirfenidone
- piroxicam
- pitavastatin: postmarketing
- pixantrone
- ponatinib
- posaconazole
- pramipexole: 1% - 4%
- pravastatin: 2.5% - 3.5%
- prednisolone phosphate
- prednisone
- progesterone
- propafenone: 0.9% - 8%
- prostacyclin: 1%
- prucalopride: common
- quazepam: 1%
- quetiapine: 0.6% - 7%
- quinapril
- quinaprilat
- rabeprazole
- raloxifene: 5.9%
- raltegravir
- raltitrexed: 2-6%
- ramipril
- ramiprilat
- ranolazine
- rapamycin: 17% - 34%
- rasagiline: 4% - 7%
- reboxetine: 2.77%
- repaglinide: 2% - 4%
- retigabine: 2% - 3%
- retinoic acid: 14%
- ribavirin: common, 1% - 24%
- rifabutin: 3%
- rifapentine
- riluzole: 2.5% - 6.1%
- rimantadine
- riociguat: 21%
- risedronate: 3.9% - 9.1%
- risperidone: 1% - 16%
- ritonavir: 0% - 5.9%
- rivaroxaban: 1.34%
- rivastigmine: common, frequent, 8% - 9%
- rizatriptan: infrequent
- rofecoxib: 2.7% - 4.7%
- roflumilast
- ropinirole: 4% - 10%
- ropivacaine: 0.1% - 3.1%
- rosuvastatin
- rotigotine: 2%
- roxithromycin
- rufinamide: 3%
- salbutamol: postmarketing, 0% - 2.7%
- salicylate
- salmeterol
- salmon calcitonin acetate
- saquinavir: common
- sertraline: common, 1% - 13%
- sevelamer: 12% - 16%
- sevelamer carbonate: 16%
- sevelamer hydrochloride: 4.7% - 16.2%
- sibutramine
- sildenafil: postmarketing, common, 2% - 17%
- simvastatin: 0.6% - 4.5%
- sitagliptin
- sitaxsentan: common, 2.01%
- sodium cromoglycate
- sodium ferric gluconate
- sofosbuvir: common
- solifenacin: 1.4% - 3.9%
- sorafenib: postmarketing, common
- sotalol: 1% - 6%
- sparfloxacin: 1.6% - 2.3%
- stavudine: common
- strontium ranelate: postmarketing
- sulfasalazine: 13%
- sulindac
- sunitinib
- tacrolimus: 0% - 28%
- tadalafil: 1% - 13%
- tamoxifen: 5.46% - 6.66%
- tamsulosin: 3.8%
- tapentadol: 1% - 3%
- tegaserod
- telavancin: uncommon
- telithromycin: 0.9% - 1.4%
- telmisartan: postmarketing, rare, uncommon, common, 1.6%
- temozolomide: common, 2% - 3%
- tenofovir: 3% - 4%
- tenofovir disoproxil fumarate: 3% - 4%
- tenoxicam: very common
- terazosin: 1.1%
- terbinafine: very common, 0% - 22%
- tesamorelin: 1.7%
- tetraen
- tetrahydrobiopterin: postmarketing
- thalidomide: 0% - 18.6%
- thiotepa
- thymidine: 2.83% - 5%
- tiagabine
- tiaprofenic acid: 3.1% - 13.5%
- ticagrelor
- ticlopidine
- tigecycline: common, 1.6% - 2.9%
- tiludronate
- timolol: 0.6%
- tinidazole: 1.4% - 1.8%
- tiotropium: 1% - 6%
- tipranavir: common
- tizanidine: frequent
- tofacitinib
- tolcapone: 4%
- tolmetin
- tolterodine: 3.1%
- topiramate: 0% - 8%
- torasemide: 1.6%
- trabectedin
- tramadol: uncommon, 1.4% - 13%
- trandolapril: 6.4%
- trandolaprilat: 6.4%
- travoprost
- treprostinil
- triamcinolone: 2.7% - 4.9%
- triamcinolone acetonide: 3.4%
- trospium chloride: 1.18% - 1.21%
- trovafloxacin
- umeclidinium
- v 1784: postmarketing, 2.2% - 12%
- valdecoxib: 7.9% - 15%
- valganciclovir: 1.83% - 6.41%
- valproate: 7% - 23%
- valsartan: 1.1%
- vandetanib: 0% - 11%
- vardenafil: 2.8% - 4%
- varenicline: 5%
- venlafaxine: 4.5% - 7%
- verapamil: 2.7%
- vigabatrin: 4% - 5%
- vilazodone: 3%
- vinflunine
- vismodegib
- voriconazole: uncommon
- zafirlukast: 1.3%
- zalcitabine
- zaleplon: frequent
- ziconotide
- zidovudine: rare, 5% - 6%
- zidovudine/lamivudine
- zileuton
- ziprasidone: 1% - 8%
- zoledronic acid: uncommon, common, 1.7% - 7.1%
- zolmitriptan: infrequent, 1% - 3%
- zolpidem: frequent, 5%
- zonisamide: 3%
- zopiclone: 2% - 6%
- zuclopenthixol
|
Drugs with this indication
|
